Page 381 - Binder2

…the system reinforces its own centrality.

It says: You need us. You can’t do this without us.

This is the illusion of necessity. A scaffolding of logistical
and clinical checkpoints that not only ensure safety—but
ensure dependency.

That’s how a $200 protein becomes a $20,000 treatment.
That’s how innovation gets tangled in red tape.
That’s how care becomes infrastructure-heavy, clinic-
bound, and exclusionary.

But Then the Molecules Changed

Now we’re entering an era where that scaffolding no longer
serves its original function. Edible biologics—especially
those produced in plants—are:

• More stable, eliminating the cold chain.
• More tolerable, thanks to mucosal delivery and
immune harmonization.
• More localized, capable of being grown regionally
or even on-site.
• More scalable and distributable, using AI to
ensure quality and reproducibility.

These characteristics remove the need for many of the
friction points the system was built around.

And when the scaffolding starts to fall away, we’re left
with a deeper question:
What was it really holding up?

379